Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q4 2023 Earnings Conference Call March 4, 2024 7:30 AM ET
Company Participants
Austin Murtagh - Stern IR
Gregory Divis - CEO
Richard Kim - Chief Commercial Officer
Thomas McHugh - CFO
Conference Call Participants
Francois Brisebois - Oppenheimer
Ami Fadia - Needham
Andrew Tsai - Jefferies
David Amsellem - Piper Sandler
Ashwani Verma - UBS
Myriam Belghiti - LifeSci Capital
Chase Knickerbocker - Craig-Hallum
Rudy Li - Leerink
Matt Kaplan - Ladenburg Thalmann
Oren Livnat - H.C. Wainwright
Operator
Greetings, and welcome to Avadel Pharmaceuticals Fourth Quarter and Full Year 2023 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. As a reminder, this conference is being recorded.
It is now my pleasure to introduce Austin Murtagh with Stern Investor Relations. You may begin.
Austin Murtagh
Good morning, and thank you for joining us on our conference call to discuss Avadel's fourth quarter and full year 2023 earnings.
As a reminder, before we begin, the following presentation includes several matters that constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. This includes statements related to expectations regarding revenue, operating expenses, and operating breakeven. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those contemplated in such forward-looking statements. These risks and uncertainties are described in Avadel's public filings under the Exchange Act, included in the Form 10-K for the year ended December 31, 2023, which was filed on February 29, 2024, and subsequent SEC filings. Except as required by law, Avadel undertakes no obligation to update or revise any forward-looking statements contained in this presentation to reflect new information, future events or otherwise.
For purposes of this conference call, the company made the decision to provide certain leading launch indicators as of January 31, 2024, in order to provide a more current snapshot of its launch progress and in consideration of the update the company provided in early January. Avadel undertakes no obligation to provide intra-quarter results in future quarters.
On the call today are Greg Divis, Chief Executive Officer; Richard Kim, Chief Commercial Officer; and Tom McHugh, Chief Financial Officer.
At this time, I'll turn the call over to Greg.
Gregory Divis
Thank you, Austin. Good morning, everyone, and thank you for joining us for a company update and to review Avadel's fourth quarter and full year 2023 results.